Chronic Twice-daily Exenatide Treatment on Beta Cell Function in New-onset T2DM

[Northerner]

Researchers conducted a 24-week, randomized, double-blinded, placebo-controlled, multicenter study with 79 participants given an oral glucose tolerance test at baseline before starting treatment and after 24 weeks of treatment. Participants were asked to report to their clinical testing site in the morning after an overnight fast of 10-12 hours.

http://www.diabetesincontrol.com/ar...tment-on-beta-cell-function-in-new-onset-t2dm